Summary
This prediction ended on 23.11.21 with a price of €48.00. During the runtime of the prediction for Bayer AG the price only changed by -0.41%. Dividends of €2.00 are taken into consideration when calculating the performance. Konrad has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bayer AG | 2.789% | 2.789% | -50.496% | -46.723% |
| iShares Core DAX® | 4.094% | 3.543% | 17.404% | 20.326% |
| iShares Nasdaq 100 | 1.424% | 0.512% | 39.212% | 55.365% |
| iShares Nikkei 225® | -1.572% | -4.633% | 15.731% | 2.146% |
| iShares S&P 500 | 1.822% | 0.963% | 30.396% | 45.950% |
According to Konrad what are the pros and cons of Bayer AG for the foreseeable future?
Pros
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Very high dividend yield expected
Good rating
Standard Investments for future growth
ROE higher than 15% per year
Could be worthwhile Investment >10% per year
Capable Management
Very good company culture
Leading role in innovation
Differentiated customer and product portfolio
Stable Large shareholder and/or long term investor
Medium risks for its business
Top 10 in its market
Small cyclical dependencies
Well known brand
Cons
Sustainability is little important
Comments by Konrad for this prediction
In the thread Bayer AG diskutieren
Buy Bayer AG
Kursziel gesetzt auf 78,0
Kursziel geändert auf 73,0
In the thread Trading Bayer AG
Die von Konrad gewählte maximale Laufzeit wurde überschritten